Bellerophon Therapeutics prices its initial public offering under range, but issues a million more shares than planned, for a gross take of $60 million.
News Well, Cardiac Assist Devices, Drug-Device Combinations, Funding Roundup, Initial Public Offering (IPO), Wall Street Beat
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vrftGN
Cap comentari:
Publica un comentari a l'entrada